New Jersey Esthetics Practice Exam 2026 – Complete Test Prep

Keratolytic agents are specifically designed to help break down and remove excess keratin, thus effectively reducing scaling, which is a common characteristic seen in psoriasis. Psoriasis is a chronic skin condition that leads to the overproduction of skin cells, resulting in thick, red patches covered with silvery scales. The primary goal of treatment with keratolytic agents in this condition is to promote the shedding of these excess skin cells and to soften the plaques associated with psoriasis.

Eczema, dermatitis, and acne may involve some level of scaling or flaking, but they do not typically respond to keratolytic agents in the same way. Management of eczema often focuses on moisturizing and anti-inflammatory treatments, while acne treatment may involve exfoliants or antimicrobial agents rather than keratolytics to address the clogged pores and bacteria. Therefore, the use of keratolytic agents is most directly associated with the treatment of psoriasis.